Treatment for Paediatric Brain Tumour - NeST Group & Geojit Join Hands with Aster's Head Start

Posted on : Jun 20, 2022


Kerala’s leading companies NeST Group and Geojit will associate with Head Start, a paediatric brain tumour initiative launched by Aster Medcity, to facilitate the education and treatment of brain-tumour affected children, who come from low-income families. NeST Group and Geojit have handed over their financial aid to the programme during a function held at Aster Medcity the other day.

Head Start, an independent initiative established under the Aster DM Foundation, has ensured financial aid to several students within a short span of time post its launch recently. The initiative aims at providing comprehensive support to patients and their families through treatment, periodic post-treatment reviews, counselling and educational assistance. The initiative’s other main goals include awareness about paediatric tumours and its early detection and promoting research on the disease with the help of medical fraternity within India and abroad.

The funds for the Head Start’s functioning is sourced through Corporate CSR funds, international conferences and association with other companies/establishments. Many companies have already joined hands with Head Start, which was launched in February, and Aster expects cooperation from more companies.